Scienture Holdings (SCNX) Current Deferred Revenue (2020 - 2022)

Scienture Holdings (SCNX) posted Current Deferred Revenue of $5127.0 for Q4 2022, up 414.76% sequentially from $996.0 in Q1 2022.

Scienture Holdings (SCNX) Current Deferred Revenue (2020 - 2022) Analysis & Trends

Scienture Holdings has reported Current Deferred Revenue for 3 years, with the latest figure at $5127.0 in Q4 2022.

Quarterly Current Deferred Revenue changed N/A year-over-year to $5127.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $5127.0 (changed N/A YoY) and the FY2022 annual result came in at $5127.0, changed N/A from the prior year.
Current Deferred Revenue climbed to $5127.0 in Q4 2022 per SCNX's latest filing, from $996.0 in the prior quarter.
Over five years, Current Deferred Revenue peaked at $305972.0 in Q1 2020 and troughed at $996.0 in Q1 2022.
A 3-year average of $55944.8 and a median of $7563.5 in 2020 frame the typical range for Current Deferred Revenue.
The sharpest annual moves came in 2021 and 2022: Current Deferred Revenue plunged 96.73% in 2021, then tumbled 90.04% in 2022.
Over 3 years, Current Deferred Revenue stood at $10000.0 in 2020, then changed by 0.0% to $10000.0 in 2021, then tumbled by 48.73% to $5127.0 in 2022.
According to Business Quant data, Current Deferred Revenue over the past three periods registered $5127.0, $996.0, and $10000.0 for Q4 2022, Q1 2022, and Q1 2021 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	High Tide	215.72 Mn	182.44 Mn	35.30 Mn
2	BioScience Health Innovations	46.85 Mn	46.14 Mn	659,483.00
3	Petmed Express	38.27 Mn	25.17 Mn	11.33 Mn
4	Scienture Holdings	18.71 Mn	18.71 Mn	335,779.00
5	Polomar Health Services	8.48 Mn	8.31 Mn	935,916.00
6	Ridgetech	58,250.67	-17.85 Mn	-

Download Data